Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Search clinical trials for: Peginterferon alfa-2b
Total 0 results
Nothing found
Sponsors and Collaborators
Nelson Mandela Academic Hospital
Pompeyo Stalin Alarcón Vigil
Centre Hospitalier du Quebec
Sub-Investigator: Łucja Bieleninik, PhD
Maria de las Mercedes Perez Rodriguez
Shenzhen Core Medical Technology CO.,LTD.
Sociedad Panameña de Hematología
Hospital Governador Celso Ramos
The Institute of Neuropsychiatry and Addictions (INAD), Parc de Salut Mar, Barcelona
Dr. Jochen Brack
Roongroj Bhidayasiri
Steven B. Kleiboeker
MYOR Ltd.
Shaoxing Mashan Street Community Health Service Center
Didem OZKAL EMINOGLU
Donald B. Kohn, M.D.
Worabe Comprehensive Specialiazed Hospital
Pharmacy Board of Sierra Leone, Ministry of Health and Sanitation
Saw Swee Hock School of Public Health
Universidad Mayor de San Simón (UMSS, Bolivia)
View Full List
Medical Conditions
Humerus Fracture Displaced Proximal
Poor Medication Adherence
0.5-14 Year Old Children With Nephroblastoma
Small Intestine Cancer
Pharmacokinetics of Ipragliflozin
Malignant Tumor of Urinary System (Disorder)
Neuroectodermal Tumor
Anticoagulant Prophylaxis/Therapy
Atherosclerosis Coronary Artery With Angina Pectoris
Control Nausea and Vomiting
Root Abscess
Macrocephaly Autism Syndrome
Bladder Cancer Recurrent
Granulomatous Disease, Chronic
Inoperable Stage III Non-small Cell Lung Cancer
Parental
Bladder Recurrence
Urinary Bladder Neurogenic Dysfunction
Endoscopic Surveillance
Memory Disorders
View Full List
Drug Interventions
Fibrin Sealant
FTD regimen
The drug "Rutan 0.1".
APG2575 800 mg
Varenicline Controlled Release 1.2 mg
Vehicle
Ceralasertib
Salvinorin A
Everolimus
Cyclosporine A
Letrozole
Biphasic insulin aspart 30
Rabeprazole, amoxicillin, tetracycline, furazolidone (only for the first 7 days), colloidal bismuth pectin (for the second 7 days)
Elafibranor 80mg
Clozapine 100 mg
Bupropion Extended Release Oral Tablet
Sparsentan
SAR408701 (Tusamitamab ravtansine)
Campath 1H
Idelalisib
View Full List
CROs by country
Contract Research Organizations in Belarus
Contract Research Organizations in Cote d'Ivoire
Contract Research Organizations in Equatorial Guinea
Contract Research Organizations in Gabon
Contract Research Organizations in Germany
Contract Research Organizations in Guatemala
Contract Research Organizations in Hong Kong
Contract Research Organizations in Mauritania
Contract Research Organizations in Papua New Guinea
Contract Research Organizations in Philippines
Contract Research Organizations in Singapore
Contract Research Organizations in Spain
Contract Research Organizations in Ukraine
CRO list by country
CROs in Tunisia
SGS
Nagy Research
ACROSS Global
Keyrus Life Science
Mesned CRO
MCT
Clinica Group
All CROs in Tunisia
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe